New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - progesterone 100mg;  ; progesterone 100mg; progesterone 100mg; progesterone 100mg - capsule - 100 mg - active: progesterone 100mg   excipient: arachis oil gelatin glycerol soya oil titanium dioxide active: progesterone 100mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 100mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide active: progesterone 100mg excipient: gelatin glycerol purified water soya oil sunflower oil titanium dioxide - adjunctive use with an oestrogen in postmenopausal women with an intact uterus (for hormone replacement therapy [hrt]).

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية جرش - jarash drug store - allantoin 1 g/100g, extr.cepae 10 g/100g, heparin sodium 5000 iu/100g - 1 g/100g, 10 g/100g, 5000 iu/100g

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية جرش - jarash drug store - allantoin 1 g/100g, extr.cepae 10 g/100g, heparin sodium 5000 iu/100g - 1 g/100g, 10 g/100g, 5000 iu/100g

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - amisulpride 100mg;  ;  ; amisulpride 100mg - tablet - 100 mg - active: amisulpride 100mg     excipient: hydrated silica lactose monohydrate magnesium stearate methylcellulose potato starch active: amisulpride 100mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - penethamate hydriodide ; benethamine penicillin ; framycetin sulphate - intramammary suspension - 100, 280, 100 mg/syringe - penethamate hydroiodide, combinations with other antibacterials - cattle - antibacterial

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية المنار - manar drug store - paclitaxel 100 mg/16.7ml - 100 mg/16.7ml

Philippines - English - FDA (Food And Drug Administration)

total nutrition corporation dba general nutrition center (gnc) natural health pharmacy; distributor: total nutrition corporation dba general nutrition center (gnc) natural health pharmacy - big 100 - tablet - 100 mg/100 mg/100 mg/100 mg/400 mcg/100 mcg/100 mcg/100 mg/100 mg/100 mcg/30 mg

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - palivizumab - injection, powder, for solution - 100 mg/vial (100mg/ml) - palivizumab 100 mg/vial (100mg/ml)

United States - English - NLM (National Library of Medicine)

precision nuclear llc - ammonia n-13 (unii: 9oqo0e343z) (ammonia n-13 - unii:9oqo0e343z) - ammonia n-13 260 mci in 1 ml - ammonia n 13 injection usp is indicated for diagnostic positron emission tomography (pet) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease. none pregnancy category c animal reproduction studies have not been conducted with ammonia n 13 injection. it is also not known whether ammonia n 13 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. ammonia n 13 injection should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk and because of the potential for radiation exposure to nursing infants from ammonia n 13 injection, use alternative infant nutrition sources (e.g., stored breast milk or infant formula) for 2 hours (> 10 half-lives of radioactive decay for n 13 isotope) after administration of the drug or avoid use of the drug, taking

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: povidone; titanium dioxide; purified talc; magnesium stearate; hypromellose; silicon dioxide; macrogol 400; sodium starch glycollate type a; maize starch - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalized tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).